You eat, and two hours later you’re already hungry. You feel exhausted after a meal, even though eating should give you energy. You accumulate weight around your belly without understanding why, even though you’re not eating more than before. Your mind sometimes fogs up, as if a light veil settles between you and your thoughts. These signals are not trivial. They don’t speak of laziness or lack of willpower. They tell a specific biological story, that of a body that no longer correctly recognizes the signal of insulin.
Insulin resistance is often discussed as if it concerned only people with diabetes. That is a mistake. This silent metabolic terrain builds long before any diagnosis appears. It develops gradually and quietly, and it now affects far more people than is commonly recognized. We see it in women in perimenopause who cannot understand why their bodies are changing so abruptly, in people with unexplained chronic fatigue, and in those whose thyroid function seems off even when standard tests show little. What is happening here goes well beyond fasting blood glucose.
When the signal no longer gets through
Insulin is a messenger hormone. It knocks on the door of your cells to tell them glucose is available for energy production. Normally the door opens, the cell takes up the glucose, and everything proceeds smoothly. When insulin resistance sets in, the lock becomes stiff. Insulin keeps knocking, but the door no longer opens as readily. The pancreas interprets this lack of response as insufficient signal and releases more insulin—then still more. Insulin levels in the blood rise abnormally high even while blood glucose remains within official reference ranges.
This state is called hyperinsulinemia. Because insulin in chronic excess does more than manage glucose, it promotes fat storage, especially around the abdomen, disrupts hormonal signaling, and is frequently accompanied by low-grade inflammation. It alters how the liver handles its reserves and can reduce tissue sensitivity, including that of the thyroid. This helps explain why some people—particularly women in perimenopause—experience unexplained fatigue, persistent brain fog, and weight gain that does not follow the usual calorie logic.
What overloads the terrain today
Insulin resistance does not appear out of nowhere. It is built, and two modern dietary factors have become dominant in recent decades. The first is excess carbohydrate intake—not only refined sugar, but the total chronic carbohydrate load from bread, rice, pasta, breakfast cereals, fruit juices, energy bars, large amounts of fruit, potatoes, and legumes. Every carbohydrate-rich intake triggers an insulin release. When this happens repeatedly throughout the day, year after year, cells gradually reduce their responsiveness. It is a logical adaptation that becomes problematic when it never stops.
The second factor is industrial seed oils high in omega-6 fatty acids—sunflower, corn, soybean, and canola oils found in most processed foods, ready meals, sauces, biscuits, and margarines. These oils, extracted under high heat and chemical processing, contribute to an imbalanced omega-6 to omega-3 ratio associated with a more inflammatory environment. They incorporate into cell membranes where insulin receptors sit. When excess omega-6 disturbs those membranes, insulin signaling becomes less efficient. Low-grade inflammation settles in and is sustained by this ongoing lipid imbalance.
These two elements—excess carbohydrate and industrial seed oils—are no longer occasional dietary missteps. They have become the modern dietary norm, appearing even in foods labeled healthy, organic, or balanced. That is precisely why insulin resistance is now so widespread. It is not a rare disease; it is a coherent biological response to an environment that continually stimulates the same metabolic pathways without allowing recovery time.
Signals that the terrain is shifting
Insulin resistance does not announce itself dramatically. It produces no pain and is easy to normalize because the same signals appear all around us. Post-meal fatigue that arrives reliably one or two hours after eating is not normal; it can reflect difficulty handling glucose, though other causes exist. Recurrent hunger, the sense of never feeling truly satisfied and needing to snack every couple of hours, often accompanies the same terrain. When insulin stays elevated, the body loses easy access to its fat stores for fuel and therefore keeps requesting glucose.
A gradually expanding waistline, even without obvious dietary change, is not merely a matter of calories. Insulin directs fat storage into visceral adipose tissue surrounding the organs. This visceral fat is metabolically active and releases inflammatory substances that further worsen insulin resistance—a self-reinforcing loop. Brain fog, the difficulty concentrating or retrieving words, can also appear in this picture. The brain depends on stable glucose use and balanced insulin signaling; when that signaling is disrupted, cellular energy production becomes less reliable. Mitochondria, the energy-producing organelles in every cell, operate less efficiently in a setting of chronic hyperinsulinemia.
Taken individually these signals are easy to dismiss. When they accumulate and persist, they outline a metabolic terrain that has moved out of balance. That terrain can be observed, understood, and addressed—not by forcing or punishing the body, but by gradually removing what overloads it.
A wider map than glucose alone
Insulin resistance does not exist in isolation. It participates in a network that touches several systems. The thyroid, for example, functions less effectively in the presence of chronic hyperinsulinemia. Research suggests that the inflammatory and obese context often linked to hyperinsulinemia can alter the conversion of T4 to active T3 and increase production of reverse T3, an inactive form that occupies receptors without delivering effect. The result can resemble functional hypothyroidism even when TSH appears normal. Persistent fatigue, a slowed metabolism, and difficulty losing weight despite effort may therefore involve the link between insulin and thyroid.
Perimenopause, the hormonal transition preceding menopause, frequently amplifies an existing insulin-resistant terrain. The gradual decline in progesterone and fluctuating estrogen alter insulin sensitivity, so what was previously manageable becomes noticeably harder. Weight gain accelerates, fatigue deepens, and brain fog thickens. This is not an inevitable consequence of age; it is a metabolic terrain shifting under changing hormonal conditions.
Chronic exhaustion that does not improve with rest often finds part of its explanation in the same terrain. When cells respond poorly to insulin, energy production falters. Mitochondria encounter an unstable supply of substrates, generate less ATP, and produce more oxidative stress. That stress, in turn, is linked to membrane damage, sustained inflammation, and further insulin resistance—another closed loop.
What research shows about the terrain’s malleability
Insulin resistance is not a fixed sentence. Cells can regain sensitivity when the chronic overload is removed. Metabolic flexibility—the ability to switch smoothly between glucose and fat as fuel—can be restored. The process is neither instant nor perfectly linear, yet it is observable.
Recent work explores the role of glutathione, a major endogenous antioxidant, in protecting against oxidative stress associated with insulin resistance. Lower glutathione status correlates with greater vulnerability to oxidative damage and, ultimately, more pronounced insulin resistance. Other studies examine epigenetic modifications—changes in gene expression that do not alter DNA sequence itself. Obesity, insulin resistance, and hyperinsulinemia are accompanied by such modifications; some appear capable of perpetuating resistance, yet they are not necessarily permanent and can shift with the metabolic environment.
These findings indicate that the body is responsive. It adapts and can return toward balance when given the appropriate conditions—through attentive observation of what and how often one eats, the quality of fats consumed, and a finer understanding of one’s own signals and reactions. The goal is not to follow an external protocol but to restore a direct relationship with one’s own body.
Re-establishing a direct relationship with your body
Insulin resistance invites a return to essentials: noticing how energy rises or crashes after meals, whether hunger returns quickly or remains steady for hours, and what the body reports when foods that overload it are reduced or reintroduced. This is not about perfection or rigid rules; it is about progressive discernment.
Nutritional recommendations change every decade, studies contradict one another, and experts disagree. In that context your own body remains an indispensable compass, refined through observation and time and, when desired, laboratory checks that confirm what you already sense. To hear what the body is saying, the background noise must first be lowered. Observe, adjust, verify.
Insulin resistance is not a modern inevitability. It is a coherent biological signal, a logical response to an environment that continually stimulates the same metabolic pathways. Understanding that signal is a way of reclaiming power—not to dominate the body, but to support what it already knows how to do once the overload is lifted.
What is at stake here extends well beyond blood glucose. It is a terrain that is built, that can degrade, and that can be restored—not by following a universal protocol, but by returning to direct, internal listening.
DISCLAIMER: This article is for informational purposes only and does not replace personalized medical advice. The dietary choices described here are based on documented anthropological and biological data, but any change to your diet, especially in the presence of medical conditions or ongoing treatment, should be discussed with a qualified healthcare professional.
Sources and References
-
Glutathione precursors: a new opportunity for dietary interventions in obesity and metabolic health? (2026 May 26), Current opinion in clinical nutrition and metabolic care
-
Samuel VT, Shulman GI. Mechanisms for insulin resistance: common threads and missing links. Cell. 2012 — mechanisms of insulin resistance
-
Shulman GI. Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. N Engl J Med. 2014 — ectopic lipids and insulin resistance
-
Corkey BE. Banting lecture 2011: hyperinsulinemia: cause or consequence? Diabetes. 2012 — hyperinsulinemia and insulin resistance
-
Wilcox G. Insulin and insulin resistance. Clin Biochem Rev. 2005 — role of insulin and insulin resistance
-
Lutchmansingh FK et al. Glutathione metabolism in type 2 diabetes and its relationship with microvascular complications and glycemia. PLoS One. 2018 — glutathione, oxidative stress and insulin resistance
-
Rönn T, Ling C. DNA methylation as a diagnostic and therapeutic target in the battle against type 2 diabetes. Epigenomics. 2015 — epigenetics and insulin resistance
-
Simopoulos AP. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med (Maywood). 2008 — omega-6/omega-3 ratio, inflammation and metabolic terrain
-
Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest. 2006 — low-grade chronic inflammation and insulin resistance